Methoxybenzoic acids and derivatives
Accela Chembio Inc 2-amino-4 | 5-dimethoxybenzoic Acid | 100g | 5653-40-7 | MFCD00011671 | 98% | Shelf Life: 1260 Days | Light Sensitive
2-amino-4 | 5-dimethoxybenzoic Acid | 100g | 5653-40-7 | MFCD00011671 | 98% | Shelf Life: 1260 Days | Light Sensitive
Medchemexpress LLC (2S,4R)-1-((S)-2-(tert-butyl)-14-(4-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl) | 2230821-40-4 | 99.7% | 1074.65 | C57H61ClFN7O9S | 5 MG
SJF-1521 is a small-molecule PROTAC degrader that selectively targets epidermal growth factor receptor (EGFR) for proteasomal degradation. It is intended for research applications investigating EGFR signaling, degradation mechanisms, and tumor biology, and is supplied with manufacturer analytical data supporting its characterization.
- Selective EGFR-targeting PROTAC degrader.
- Demonstrated to induce EGFR degradation in OVCAR8 cells.
- High reported purity (≈99.7%).
- Characterized by molecular weight and structural analytical data.
- Supplied in small research quantities suitable for in vitro studies.
Medchemexpress LLC 2-Hydroxy-4-methoxybenzoic acid (4-Methoxysalicylic Acid) | 2237-36-7 | 99.6% | C8H8O4 | 1 ML
2-Hydroxy-4-methoxybenzoic acid (4-Methoxysalicylic Acid) is a phenolic compound isolated from *Hemidesmus indicus* and other plants. It exhibits anti-diabetic, hypolipidemic, hepatoprotective, and anti-snake venom activities. This compound can be utilized in the study of diabetes and its complications, liver diseases, immune-related diseases, and snake venom poisoning.
- Isolated from *Hemidesmus indicus* and other plants
- Exhibits anti-diabetic, hypolipidemic, hepatoprotective, and anti-snake venom activities
- Can be utilized in the study of diabetes and its complications
- Can be utilized in the study of liver diseases
- Can be utilized in the study of immune-related diseases
- Can be utilized in the study of snake venom poisoning
- Has a CC50 of > 40 μM against RAW264.7 cells
- Soluble in DMSO (50 mg/mL)